(Translated by https://www.hiragana.jp/)
Diabetes and aortic dissection: unraveling the role of 3-hydroxybutyrate through mendelian randomization

Diabetes and aortic dissection: unraveling the role of 3-hydroxybutyrate through mendelian randomization

Cardiovasc Diabetol. 2024 May 7;23(1):159. doi: 10.1186/s12933-024-02266-3.

Abstract

Background: In observational and experimental studies, diabetes has been reported as a protective factor for aortic dissection. 3-Hydroxybutyrate, a key constituent of ketone bodies, has been found to favor improvements in cardiovascular disease. However, whether the protective effect of diabetes on aortic dissection is mediated by 3-hydroxybutyrate is unclear. We aimed to investigate the causal effects of diabetes on the risk of aortic dissection and the mediating role of 3-hydroxybutyrate in them through two-step Mendelian randomization.

Materials and methods: We performed a two-step Mendelian randomization to investigate the causal connections between diabetes, 3-hydroxybutyrate, and aortic dissection and calculate the mediating effect of 3-hydroxybutyrate. Publicly accessible data for Type 1 diabetes, Type 2 diabetes, dissection of aorta and 3-hydroxybutyrate were obtained from genome-wide association studies. The association between Type 1 diabetes and dissection of aorta, the association between Type 2 diabetes and dissection of aorta, and mediation effect of 3-hydroxybutyrate were carried out separately.

Results: The IVW method showed that Type 1 diabetes was negatively associated with the risk of aortic dissection (OR 0.912, 95% CI 0.836-0.995), The weighted median, simple mode and weighted mode method showed consistent results. The mediated proportion of 3-hydroxybutyrate on the relationship between Type 1 diabetes and dissection of aorta was 24.80% (95% CI 5.12-44.47%). The IVW method showed that Type 2 diabetes was negatively associated with the risk of aortic dissection (OR 0.763, 95% CI 0.607-0.960), The weighted median, simple mode and weighted mode method showed consistent results. 3-Hydroxybutyrate does not have causal mediation effect on the relationship between Type 2 diabetes and dissection of aorta.

Conclusion: Mendelian randomization study revealed diabetes as a protective factor for dissection of aorta. The protective effect of type 1 diabetes on aortic dissection was partially mediated by 3-hydroxybutyrate, but type 2 diabetes was not 3-hydroxybutyrate mediated.

Keywords: 3-hydroxybutyrate; Diabetes; Dissection of aorta; Genome-wide association study (GWAS); Mendelian randomization (MR).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Hydroxybutyric Acid* / blood
  • Aortic Aneurysm* / epidemiology
  • Aortic Aneurysm* / etiology
  • Aortic Aneurysm* / genetics
  • Aortic Dissection* / epidemiology
  • Aortic Dissection* / etiology
  • Aortic Dissection* / genetics
  • Biomarkers / blood
  • Diabetes Mellitus, Type 1* / diagnosis
  • Diabetes Mellitus, Type 1* / epidemiology
  • Diabetes Mellitus, Type 1* / genetics
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetes Mellitus, Type 2* / epidemiology
  • Diabetes Mellitus, Type 2* / genetics
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study*
  • Humans
  • Mediation Analysis
  • Mendelian Randomization Analysis*
  • Phenotype
  • Protective Factors
  • Risk Assessment
  • Risk Factors

Substances

  • 3-Hydroxybutyric Acid
  • Biomarkers